Envestnet Asset Management
CRBU icon

Envestnet Asset Management’s Caribou Biosciences CRBU Stock Holding History

Envestnet Asset Management’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$58.1K Sell
30,586
-1,721
-5% -$2.95K ﹤0.01% 4661
2025
Q4 		$51.4K Sell
32,307
-6,461
-17% -$13.6K ﹤0.01% 4415
2025
Q3 		$90.3K Sell
38,768
-279,889
-88% -$528K ﹤0.01% 4437
2025
Q2 		$402K Buy
318,657
+274,812
+627% +$270K ﹤0.01% 3862
2025
Q1 		$40K Sell
43,845
-2,456
-5% -$3.19K ﹤0.01% 4304
2024
Q4 		$73.6K Buy
46,301
+14,021
+43% +$28.2K ﹤0.01% 4239
2024
Q3 		$63.3K Sell
32,280
-868
-3% -$1.78K ﹤0.01% 4166
2024
Q2 		$54.4K Buy
+33,148
New +$106K ﹤0.01% 4099

Other funds holding CRBU

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.58B AUM 138.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return